BBA clinical最新文献

{"title":"Accumulated substancies and calorific capacity in adipose tissue: Physical and chemical clinical trial","authors":"Kuat Oshakbayev ,&nbsp;Bibazhar Dukenbayeva ,&nbsp;Gulnar Togizbayeva ,&nbsp;Meruyert Gazaliyeva ,&nbsp;Alma Syzdykova ,&nbsp;Kanat Daurenbekov ,&nbsp;Pernekul Issa","doi":"10.1016/j.bbacli.2017.05.002","DOIUrl":"10.1016/j.bbacli.2017.05.002","url":null,"abstract":"<div><h3>Aim</h3><p>To study physical and chemical structures and properties including calorific value of human adipose tissue in different anatomical location in autopsy-assigned clinical trial.</p></div><div><h3>Methods</h3><p>A pilot physical and chemical descriptive randomized autopsy-assigned trial. Adipose tissue 252 sampled from 36 individuals at autopsy who between 36 and 63<!--> <!-->years old died from road accidents. Interventions: Chemical functional groups and calorific value were studied using infrared and atomic adsorptive spectrometries, elemental chemical analysis and differential scanning calorimetry. Adipose tissue was sampled from the 7 various anatomical locations.</p></div><div><h3>Results</h3><p>The highest levels of the analysed chemical substancies were found in dense atherosclerotic plaque. Dense atherosclerotic plaque contains the most of metabolic products, organic and inorganic elements. Dense atherosclerotic plaque has the most of calorific value. The lowest calorific capacity has a pararenal fat.</p></div><div><h3>Conclusions</h3><p>Human body lipids serve as a harbor for various organic substances, they may absorb different metabolic products, and they have different calorific capacity depending on their location and forms. Atherosclerotic plaque contains the most of organic and inorganic elements, and brings the highest energy potential.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35099247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease","authors":"G. Vinothkumar ,&nbsp;C. Kedharnath ,&nbsp;S. Krishnakumar ,&nbsp;S. Sreedhar ,&nbsp;K. Preethikrishnan ,&nbsp;S. Dinesh ,&nbsp;A. Sundaram ,&nbsp;D. Balakrishnan ,&nbsp;G. Shivashekar ,&nbsp;Sureshkumar ,&nbsp;P. Venkataraman","doi":"10.1016/j.bbacli.2017.06.001","DOIUrl":"10.1016/j.bbacli.2017.06.001","url":null,"abstract":"<div><h3>Background</h3><p>Cognitive dysfunction has been increasingly recognized in chronic kidney disease (CKD) patients. Senile plaques are important pathophysiological characteristic of cognitive dysfunction. The major component of plaques is the amyloid β (Aβ) peptide released from proteolytic cleavage of amyloid precursor protein (APP). Plasma Aβ has been a focus of the growing literature on blood based biomarkers for cognitive dysfunction. Oxidative stress is prevalent in CKD and it plays an important role in cognitive dysfunction. Increased oxidative stress leads to cause cleavage of APP and Aβ production. The aim of this study is to assess the antioxidant status and Aβ₄₂ levels in plasma of CKD patients with cognitive dysfunction compared to CKD without cognitive dysfunction.</p></div><div><h3>Methods</h3><p>A total of 60 subjects divided into 30 CKD without cognitive dysfunction and 30 CKD with cognitive dysfunction based on neuropsychological assessment tests. To compare antioxidant status and Aβ₄₂ levels in plasma, the following groups such as healthy subjects (n<!--> <!-->=<!--> <!-->30), normocytic normochromic anemia (n<!--> <!-->=<!--> <!-->30) and Alzheimer's disease (AD, n<!--> <!-->=<!--> <!-->10) patients were also maintained. Plasma Superoxide dismutase (SOD), Catalase (CAT), Glutathione peroxidase (GPx), Reduced glutathione (GSH) and lipid peroxidation (LPO) were determined by spectrophotometrically. Aβ level was determined by immunoblotting method. The parameters were statistically compared with healthy, normocytic normochromic anemia and AD subjects.</p></div><div><h3>Results</h3><p>Like AD subjects, significantly increased Aβ and LPO level while decreased SOD, CAT, GPx and GSH levels were observed in plasma of CKD patients with cognitive dysfunction when compared to healthy, CKD without cognitive dysfunction and normocytic normochromic anemic subjects.</p></div><div><h3>Conclusion</h3><p>Results suggest that elevated plasma oxidative stress and Aβ were seen in CKD patients with cognitive dysfunction may be attributed to pathological changes within the brain.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35162899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. I. A new assay for lysosomal α-N-acetylgalactosaminidase","authors":"Simon P.J. Albracht ,&nbsp;Erik Allon ,&nbsp;Johannes van Pelt","doi":"10.1016/j.bbacli.2017.10.001","DOIUrl":"10.1016/j.bbacli.2017.10.001","url":null,"abstract":"<div><p>This paper presents a new assay to determine the activity of the lysosomal enzyme α-<em>N</em>-acetylgalactosaminidase (Naga, EC 3.2.1.49) in human serum. It is based on the use of a new chromogenic substrate, DNP-α-GalNAc (2,4-dinitrophenyl-<em>N</em>-acetyl-α-D-galactosaminide) and is performed at pH<!--> <!-->4.3 and 37<!--> <!-->°C. This allows continuous monitoring of the absorbance of the released DNP. The assay can be performed with a standard spectrophotometer. Compared to established methods using an endpoint assay with MU-α-GalNAc (4-methylumbelliferyl-GalNAc), the present method gives a ca. 3-fold higher specific activity, while only one tenth of the serum concentration in the assay is required. Hence, the assay is at least 30-fold more sensitive than that with MU-α-GalNAc. The pH dependence of the reaction with DNP-α-GalNAc in the pH<!--> <!-->3.5 to 6.5 region, while using 4% serum in the assay, shows only one peak around pH<!--> <!-->4. This pH optimum is similar to that reported with MU-α-GalNAc. In the accompanying paper (S.P.J Albracht and J. Van Pelt (2017) Multiple <em>exo</em>-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-<em>N</em>-acetylgalactosaminidase-like activities in the pH 5 to 8 region. BBA Clin. 8 (2017) 90-96), the method is used to show that, under special assay conditions, three more Naga-like activities can be uncovered in human serum.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35634402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Iron retention in iron-fortified rice and use of iron-fortified rice to treat women with iron deficiency: A pilot study","authors":"Losso J.N. ,&nbsp;Karki N. ,&nbsp;Muyonga J. ,&nbsp;Wu Y. ,&nbsp;Fusilier K. ,&nbsp;Jacob G. ,&nbsp;Yu Y. ,&nbsp;Rood J.C. ,&nbsp;Finley J.W. ,&nbsp;Greenway F.L.","doi":"10.1016/j.bbacli.2017.09.001","DOIUrl":"10.1016/j.bbacli.2017.09.001","url":null,"abstract":"<div><h3>Objectives</h3><p>1. Evaluate the effect of washing and cooking iron-fortified rice on iron retention and bioavailability. 2. Evaluate the effect of iron-fortified rice on women with iron deficiency anemia</p></div><div><h3>Methods</h3><p>1. Iron-fortified rice (18<!--> <!-->mg/100<!--> <!-->g as FeSO₄) was cooked in Baton Rouge, Louisiana (C), rinsed and cooked (RC), fried and cooked (FC), cooked with extra water (CW), or soaked and cooked with extra water (SCW), and iron retention was determined. 2. Rice samples were cooked in Kampala, Uganda in a lab (C-Uganda) and households using traditional cooking method (TC-Uganda) and iron retention were determined. 3. Seventeen women with iron deficiency (low iron and/or low ferritin) anemia were randomized to 100<!--> <!-->g/d of rice (two cooked 0.75 cup servings) for two weeks containing 18<!--> <!-->mg/d iron (supplemented) or 0.5<!--> <!-->mg/d iron (un-supplemented). Hemoglobin and hematocrit were evaluated at baseline and 2<!--> <!-->weeks with other measures of iron metabolism.</p></div><div><h3>Results</h3><p>1. Iron retention, from highest to lowest, was (C), (RC), (FC), (C-Uganda), (CW), (SCW) and (TC-Uganda). 2. Seventeen women were randomized and 15 completed the study (hemoglobin 10.6<!--> <!-->±<!--> <!-->1.6<!--> <!-->g, hematocrit 33.7<!--> <!-->±<!--> <!-->4.1%), 9 in the iron-fortified rice group and 6 in the un-fortified rice group. The iron-fortified group had a greater increase in hemoglobin (0.82<!--> <!-->g, p<!--> <!-->=<!--> <!-->0.0035) and Hematocrit (1.83%, p<!--> <!-->=<!--> <!-->0.0248) with directional differences in other measures of iron metabolism favoring the iron-fortified group.</p></div><div><h3>Conclusions</h3><p>Iron-fortified rice increased hemoglobin and hematocrit in women with iron-deficient anemia. Iron deficiency and anemia are widespread in Southeast Asia and Africa and undermine development in these regions.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35463823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Regulation of cardiac CACNB2 by microRNA-499: Potential role in atrial fibrillation","authors":"Tian-You Ling,&nbsp;Xiao-Li Wang,&nbsp;Qiang Chai,&nbsp;Tong Lu,&nbsp;John M. Stulak,&nbsp;Lyle D. Joyce,&nbsp;Richard C. Daly,&nbsp;Kevin L. Greason,&nbsp;Li-Qun Wu,&nbsp;Win-Kuang Shen,&nbsp;Yong-Mei Cha,&nbsp;Hon-Chi Lee","doi":"10.1016/j.bbacli.2017.02.002","DOIUrl":"10.1016/j.bbacli.2017.02.002","url":null,"abstract":"<div><p>The L-type calcium channel (LTCC) is one of the major ion channels that are known to be associated with the electrical remodeling of atrial fibrillation (AF). In AF, there is significant downregulation of the LTCC, but the underlying mechanism for such downregulation is not clear. We have previously reported that microRNA-499 (miR-499) is significantly upregulated in patients with permanent AF and that <em>KCNN3,</em> the gene that encodes the small-conductance calcium-activated potassium channel 3 (SK3), is a target of miR-499. We found that CACNB2, an important subunit of the LTCC, is also a target of miR-499. We hypothesize that miR-499 plays an important role in AF electrical remodeling by regulating the expression of <em>CACNB2</em> and the LTCC. In atrial tissue from patients with permanent AF, CACNB2 was significantly downregulated by 67% (<em>n</em> <!-->=<!--> <!-->4, <em>p</em> <!-->&lt;<!--> <!-->0.05) compared to those from patients with no history of AF. Transfection of miR-499 mimic into HL-1 cells, a mouse hyperplastic atrial cardiac myocyte cell-line, resulted in the downregulation of CACNB2 protein expression, while that of miR-499 inhibitor upregulated CACNB2 protein expression. Binding of miR-499 to the 3′ untranslated region of <em>CACNB2</em> was confirmed by luciferase reporter assay and by the increased presence of <em>CACNB2</em> mRNA in Argonaute pulled-down microRNA-induced silencing complexes after transfection with the miR-499 mimic. In addition, downregulation of CACNB2 resulted in the downregulation of protein levels of the pore-forming α-subunit (CACNA1C). In conclusion, upregulation of atrial miR-499 induces the downregulation of CACNB2 expression and may contribute to the electrical remodeling in AF.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.02.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34765960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice","authors":"Xingxuan He ,&nbsp;Shaalee Dworski ,&nbsp;Changzhi Zhu ,&nbsp;Victor DeAngelis ,&nbsp;Alex Solyom ,&nbsp;Jeffrey A. Medin ,&nbsp;Calogera M. Simonaro ,&nbsp;Edward H. Schuchman","doi":"10.1016/j.bbacli.2017.02.001","DOIUrl":"10.1016/j.bbacli.2017.02.001","url":null,"abstract":"<div><p>A series of studies were carried out in Farber disease (OMIM #<span>228000</span><svg><path></path></svg>) cells and mice to evaluate the feasibility of enzyme replacement therapy (ERT) for this disorder. Media from Chinese hamster ovary (CHO) cells overexpressing human recombinant acid ceramidase (rhAC) was used to treat fibroblasts from a Farber disease patient, leading to significantly reduced ceramide. We also found that chondrocytes from Farber disease mice had a markedly abnormal chondrogenic phenotype, and this was corrected by rhAC as well. Acute dosing of rhAC in Farber mice confirmed the enzyme's bioactivity in vivo, and showed that it could be safely administered at doses up to 50<!--> <!-->mg/kg. These studies also revealed little or no re-accumulation of ceramide in tissues for at least 7<!--> <!-->days after enzyme administration. Once weekly administration of rhAC moderately improved survival of the mice, which could be enhanced by starting enzyme administration at an earlier age (3<!--> <!-->days vs. 3<!--> <!-->weeks). Repeat administration of the enzyme also led to normalization of spleen size, significantly reduced plasma levels of monocyte chemoattractant protein 1 (MCP-1), reduced infiltration of macrophages into liver and spleen, and significantly reduced ceramide and sphingosine in tissues. Overall, we conclude that ERT should be further developed for this debilitating and life-threatening disorder.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.02.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34796953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment","authors":"Moon K. Song ,&nbsp;David S. Bischoff ,&nbsp;Albert M. Song ,&nbsp;Koichi Uyemura ,&nbsp;Dean T. Yamaguchi","doi":"10.1016/j.bbacli.2016.09.003","DOIUrl":"10.1016/j.bbacli.2016.09.003","url":null,"abstract":"<div><h3>Background</h3><p>Association of Alzheimer's Disease (AD) with Type 2 Diabetes (T2D) has been well established. Cyclo(His-Pro) plus zinc (Cyclo-Z) treatment ameliorated diabetes in rats and similar improvements have been seen in human patients. Treatment of amyloid precursor protein (APP) transgenic mice with Cyclo-Z exhibited memory improvements and significantly reduced Aβ-40 and Aβ-42 protein levels in the brain tissues of the mice.</p></div><div><h3>Scope of review</h3><p>Metabolic relationship between AD and T2D will be described with particular attention to insulin sensitivity and Aβ degradation in brain and plasma tissues. Mechanistic effect of insulin degrading enzyme (IDE) in decreasing blood glucose and brain Aβ levels will be elucidated. Cyclo-Z effects on these biochemical parameters will be discussed.</p></div><div><h3>Major conclusion</h3><p>Stimulation of IDE synthesis is effective for the clinical treatment of metabolic diseases including AD and T2D.</p></div><div><h3>General significance</h3><p>Cyclo-Z might be the effective treatment of AD and T2D by stimulating IDE synthesis.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2016.09.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54181695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lysozyme association with circulating RNA, extracellular vesicles, and chronic stress","authors":"Sarah K. Abey ,&nbsp;Yuana Yuana ,&nbsp;Paule V. Joseph ,&nbsp;Natnael D. Kenea ,&nbsp;Nicolaas H. Fourie ,&nbsp;LeeAnne B. Sherwin ,&nbsp;Gregory E. Gonye ,&nbsp;Paul A. Smyser ,&nbsp;Erin S. Stempinski ,&nbsp;Christina M. Boulineaux ,&nbsp;Kristen R. Weaver ,&nbsp;Christopher K.E. Bleck ,&nbsp;Wendy A. Henderson","doi":"10.1016/j.bbacli.2016.12.003","DOIUrl":"10.1016/j.bbacli.2016.12.003","url":null,"abstract":"<div><h3>Background</h3><p>Stress has demonstrated effects on inflammation though underlying cell-cell communication mechanisms remain unclear. We hypothesize that circulating RNAs and extracellular vesicles (EVs) in patients with chronic stress contain signals with functional roles in cell repair.</p></div><div><h3>Methods</h3><p>Blood transcriptome from patients with Irritable Bowel Syndrome versus controls were compared to identify signaling pathways and effectors. Plasma EVs were isolated (size-exclusion chromatography) and characterized for effectors' presence (immunogold labelling-electron microscopy). Based on transcriptome pathways and EV-labelling, lysozyme's effects on cell migration were tested in human colon epithelial CRL-1790 cells and compared to the effects of CXCL12, a migration inducer (wound assay). The effect of lysozyme on immune-linked mRNA and protein levels in cells which survived following serum starvation and scratch wound were investigated (NanoString).</p></div><div><h3>Results</h3><p>Blood transcriptomes revealed pyridoxal 5’phosphate salvage, pyrimidine ribonucleotides salvage pathways, atherosclerosis, and cell movement signaling with membrane CD9 and extracellular lysozyme as effectors. Plasma EVs showed labelling with CD9, mucins, and lysozyme. This is the first identification of lysozyme on plasma EVs. In CRL-1790 cells, lysozyme induced migration and repaired scratch wound as well as CXCL12. Immune mRNA and protein expressions were altered in cells which survived following serum starvation and scratch wound, with or without lysozyme in serum-free media post-wounding: CD9, IL8, IL6 mRNAs and CD9, NT5E, PD-L1 proteins.</p></div><div><h3>Conclusions</h3><p>Repair and inflammatory signals are identified in plasma EVs and circulating RNAs in chronic stress. Registered <span>clinicaltrials.gov</span><svg><path></path></svg> #<span>NCT00824941</span><svg><path></path></svg></p></div><div><h3>General significance</h3><p>This study highlights the role of circulating RNAs and EVs in stress.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2016.12.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54182082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Applying a systems approach to thyroid physiology: Looking at the whole with a mitochondrial perspective instead of judging single TSH values or why we should know more about mitochondria to understand metabolism","authors":"Roy Moncayo,&nbsp;Helga Moncayo","doi":"10.1016/j.bbacli.2017.03.004","DOIUrl":"10.1016/j.bbacli.2017.03.004","url":null,"abstract":"<div><p>Classical thinking in endocrine physiology squeezes our diagnostic handling into a simple negative feedback mechanism with a controller and a controlled variable. In the case of the thyroid this is reduced to TSH and fT3 and fT4, respectively. The setting of this tight notion has no free space for any additions. In this paper we want to challenge this model of limited application by proposing a construct based on a systems approach departing from two basic considerations. In first place since the majority of cases of thyroid disease develop and appear during life it has to be considered as an acquired condition. In the second place, our experience with the reversibility of morphological changes makes the autoimmune theory inconsistent.</p><p>While medical complexity can expand into the era of OMICS as well as into one where manipulations with the use of knock-outs and -ins are common in science, we have preferred to maintain a simple and practical approach. We will describe the interactions of iron, magnesium, zinc, selenium and coenzyme Q10 with the thyroid axis. The discourse will be then brought into the context of ovarian function, i.e. steroid hormone production. Finally the same elemental players will be presented in relation to the basic mitochondrial machinery that supports the endocrine.</p><p>We propose that an intact mitochondrial function can guard the normal endocrine function of both the thyroid as well as of the ovarian axis. The basic elements required for this function appear to be magnesium and iron. In the case of the thyroid, magnesium-ATP acts in iodine uptake and the heme protein peroxidase in thyroid hormone synthesis. A similar biochemical process is found in steroid synthesis with cholesterol uptake being the initial energy-dependent step and later the heme protein ferredoxin 1 which is required for steroid synthesis. Magnesium plays a central role in determining the clinical picture associated with thyroid disease and is also involved in maintaining fertility. With the aid of 3D sonography patients needing selenium and/or coenzyme Q10 can be easily identified. By this we firmly believe that physicians should know more about basic biochemistry and the way it fits into mitochondrial function in order to understand metabolism. Contemplating only TSH is highly reductionistic.</p></div><div><h3>Outline</h3><p></p><ul><li><span>•</span><span><p>Author's profiles and motivation for this analysis</p></span></li><li><span>•</span><span><p>The philosophical alternatives in science and medicine</p></span></li><li><span>•</span><span><p>Reductionism vs. systems approach in clinical thyroid disease guidelines</p></span></li><li><span>•</span><span><p>The entry into complexity: the involvement of the musculoskeletal system</p></span></li><li><span>•</span><span><p>Integrating East and West: teachings from Chinese Medicine and from evidence based medicine (EBM)</p></span></li><li><span>•</span><span><p>Can a mathematical model ","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.03.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34919831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detection of copy number alterations in cell-free tumor DNA from plasma","authors":"Olga Østrup ,&nbsp;Lise Barlebo Ahlborn ,&nbsp;Ulrik Lassen ,&nbsp;Morten Mau-Sørensen ,&nbsp;Finn Cilius Nielsen","doi":"10.1016/j.bbacli.2017.03.006","DOIUrl":"10.1016/j.bbacli.2017.03.006","url":null,"abstract":"<div><h3>Background</h3><p>Somatic copy number alterations (SCNAs) occurring in tumors can provide information about tumor classification, patient's outcome or treatment targets. Liquid biopsies, incl. plasma samples containing circulating cell-free tumor DNA (ccfDNA) can be used to assess SCNAs for clinical purposes, however specify and reliability of methods have to be tested.</p></div><div><h3>Methods</h3><p>SNP microarrays (Affymetrix) were used to generate whole-genome copy number profiles from plasma ccfDNA (OncoScan) and paired tumor biopsies (CytoScan) from ten patients with metastatic cancers. Numerical, segmental and focal SCNAs were assessed using ASCAT/TuScan and SNP-FASST2.</p></div><div><h3>Results</h3><p>Aberrations in ccfDNA in 4 patients resembled numerical (76%) and segmental (80%) aberrations in tDNA. Three patients represented low correlation due to postponed sampling time, ccfDNA quality and possible treatment interference. Breakpoints of high-amplitude amplification were assessed with high accuracy and relative breakpoints difference of only 7% (0.02–37%). Similarly, biallelic losses were reliably detected. Array was 100% successful in detection of SCNAs on clinically relevant genes compared to SCNAs in tumor biopsies. Tracking of SCNAs changes during the treatment course of one patient also indicated that apoptosis/necrosis of non-cancerous cells presumably induced by treatment can influence ccfDNA composition and introduce false-negative findings into the analysis of liquid biopsies.</p></div><div><h3>Conclusions</h3><p>Genomic alterations detected in ccfDNA from liquid biopsies by comprehensive SNP array are reliable source for information for stratification of patients for targeted treatment.</p></div><div><h3>General significance</h3><p>Clinically relevant SCNAs can be detected in ccfDNA with high resolution and can therefore serve as an alternative to tumor biopsy in defining treatment targets.</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.03.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34919938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}